All Episodes
340B Unscripted — 97 episodes
Ep 91 | More 340B Updates
Ep 90 | 340B Updates
Ep 89 | 340B Pricing Removal & GPO Prohibition Court Case Ruling
Ep 88 | Hospital Child Sites – Recent Developments with CMS Provider-Based Rules and 340B Child Site Eligibility Timing
Ep 87 | HRSA 340B Rebate Request For Information (RFI)
Ep 86 | Updates in 340B
Ep 85 | HRSA Information Collection Request – 340B Enrollment, Registration & Recertification
Ep 84 | CMS OPPS Drug Acquisition Cost Survey (ODACS)
Ep 83 | 340B Rebates Are on Hold
Ep 82 | Recap of 340B Developments from 2025
Ep 81 | 340B Rebate Q&A with Beacon
Ep 80 | 340B Updates, including CMS CY26 OPPS Final Rule and Rebate Developments
Ep 79 | 340B Rebate Model Update
Ep 78 | Government Shutdown, Most Favored Nations Pricing and Direct-to-Consumer Pharmacy Supply Chain Discussion
Ep 77 | DSH Hospital Threats
Ep 76 | HRSA DRL Updates & 340B Rebate Comments
Ep 75 | 340B Rebate Guidance Update – HRSA FAQs
Ep 74 | Annual Hospital Recertification & Proposed Changes to OPAIS
Ep 73 | Coalition Recap & 340B Rebate Guidance Release
Ep 72 | Insulin & EpiPen 340B Policy Changes for FQHCs
Ep 71 | 2025 Midyear 340B Review – Conversation with Ted Slafsky
Ep 70 | 340B Updates – IRA Guidance and Rebate Models
Ep 69 | Quick 340B Update
Ep 68 | 340B Hot Topics Discussion
Ep 67 | 340B Location Issues – Webinar Follow Up
Ep 66 | OPAIS Database Compliance Tips
Ep 65 | IRA Impact on 340B
Ep 64 | 340B Winter Coalition Conference Recap
Ep 63 | Provider-Based Rules & 340B
Ep 62 | Updates from Ongoing 340B Litigation
Ep 61 | What Else is Happening in 340B to Start 2025
Ep 60 | What’s Happening in 340B to Start 2025
Ep 59 | Recap of 340B Developments in 2024
Ep 58 | Sanofi 340B Credit Model
Ep 57 | Post-Election Outcome & 340B Implications
Ep 56 | 2024 General Election Outlook & 340B
Ep 55 | All About 340B Modifiers
Ep 54 | 340B Operations Discussion – “Clean Site” Locations
Ep 53 | J&J 340B Rebate Model Follow-Up Discussion
Ep 52 | 340B Smorgasbord - Contract Pharmacy Legislation, ADR, Section 1115 Waiver Days & 340B Rebate Models
Ep 51 | CMS Medicaid Drug Rebate Program & “Covered Outpatient Drug” Definition
Ep 50 | 340B Q&A with Hoopii
Ep 49 | HRSA Audit Trends and Manufacturer Audit Activity – Conversation with Emily Cook
Ep 48 | 2024 Midyear 340B Review - Conversation with Ted Slafsky
Ep 47 | Alternate Distribution Models & 340B
Ep 46 | Revisiting the Intersection of the IRA Medicare Drug Pricing Program & 340B – Conversation with Jeff Davis
Ep 45 | Chevron Doctrine & 340B
Ep 44 | Pharmacotherapy Clinic Services & 340B
Ep 43 | Getting to Know the HRSA DRL – DRL 8 Self-Disclosure Documentation and DRL 9 Medicaid Billing Information
Ep 42 | Getting to Know the HRSA DRL – Grantee Considerations Part 2
Ep 42 | Getting to Know the HRSA DRL – Grantee Considerations Part 1
Ep 41 | 340B News & Notes
Ep 40 | Getting to Know the HRSA DRL: DRL 5 Purchasing Documentation and DRL 7 Entity-Owned Pharmacy Documentation
Ep 39 | A Revisit of Ongoing Contract Pharmacy Restrictions
Ep 38 | Getting to Know the HRSA DRL: DRL 4 Provider List and DRL 6 Contract Pharmacy Documentation
Ep 37 | Getting to Know HRSA DRL: Part 3 - 340B Universe Data
Ep 36 | Getting to Know HRSA DRL: Part 2 - CE Eligibility Documentation
Ep 35 | Top 10 Developments in 340B for 2023
Ep 34 | Maintaining 340B Compliance: The Importance of Self-Auditing
Ep 33 | Thoughts on the Genesis v. Becerra Court Ruling
Ep 32 | Getting to Know the HRSA DRL: Part 1 – Policies & Procedures
Bonus Ep 2 | HRSA Notice Addressing 340B Registration Requirements
Ep 31 | Answering 340B FAQs - Rob vs. ChatGPT
Ep 30 | Turnkey Pharmacy Solutions, Whiteboards & 340B Stuff
Ep 29 | The Intersection Between the Inflation Reduction Act (IRA) & 340B – Conversation with Jeff Davis
Ep 28 | 340B Conversation with Emily Cook - Part 2
Ep 27 | 340B Conversation with Emily Cook - Part 1
Ep 26 | First Year Anniversary of the 340B Unscripted Podcast - Q & A Session
Ep 25 | 340B Coalition Summer Conference Recap - Part 2
Ep 24 | 340B Coalition Summer Conference Recap
Ep 23 | 340B and the Medicare Cost Report
Ep 22 | Maintaining 340B Compliance: Medicaid Duplicate Discount Prevention
Ep 21 | Thoughts on 340B & Biosimilar Uptake
Ep 20 | 340B History Lesson – The Morford Letter
Bonus Ep 1 | New 340B Location Qualification and FAQ 4301 Update
Ep 19 (Update) | HRSA FAQ 4301 Developments
Ep 19 | 340B D.C. Update – Conversation with Ted Slafsky
Ep 18 | 340B Program Reform – A Conversation with NACHC
Ep 17 | 2023 Winter Coalition Recap and More!
Ep 16 | Dissecting Recent 340B Program Reform Proposals
Ep 15 | Building Your 340B Team
Ep 14 | All About 340B Grantees (Part 2)
Ep 14 | All About 340B Grantees (Part 1)
Ep 13 | Update on Manufacturer Restrictions for 340B Contract Pharmacies
Ep 12 | Pharmacy Benefit Optimization for 340B Covered Entities
Ep 11 | Trends in Direct Order Procurement
Ep 10 | Top 10 Developments in 340B for 2022
Ep 9 | TPA Transition Tips and Tricks
Ep 8 | Trulla - Modernizing Pharmacy Procurement
Ep 7 | Don’t be Haunted by a HRSA Audit!
Ep 6 | 340B NYT Article: Are You Next?
Ep 5 | Weighing the Risk: Referral Capture vs. Continuum of Care
Ep 4 | Inflation Reduction Act’s 340B Impact
Ep 3 | Future Outlook of 340B Contract Pharmacy Limitations
Ep 2 | 2022 340B Coalition Summer Recap
Ep 1 | 340B Patient Definition Roundtable
Ep 0 | 340B Unscripted